{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:12:58Z","timestamp":1791364378277,"version":"4.3.1"},"reference-count":166,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010451","name":"Hunan Province Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbcan.2025.189487","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:08:23Z","timestamp":1761354503000},"page":"189487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune archetypes TIME classification system for nasopharyngeal carcinoma: A new direction for precision immunotherapy"],"prefix":"10.1016","volume":"1880","author":[{"given":"Fei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6717","key":"10.1016\/j.bbcan.2025.189487_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq7248","article-title":"Cancer immunotherapy by gammadelta T cells","volume":"386","author":"Hayday","year":"2024","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189487_bb0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189487_bb0015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.annonc.2024.08.2344","article-title":"Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial","volume":"35","author":"Toh","year":"2024","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189487_bb0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/hed.27931","article-title":"Evaluating the reduction of elective radiotherapy fields for de novo metastatic nasopharyngeal carcinoma in the immunotherapy era","volume":"47","author":"Jin","year":"2024","journal-title":"Head Neck"},{"issue":"10445","key":"10.1016\/j.bbcan.2025.189487_bb0025","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/S0140-6736(24)00810-9","article-title":"Immunotherapeutics in nasopharyngeal carcinoma: a relentless CONTINUUM of success","volume":"403","author":"Saba","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2025.189487_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2024.106867","article-title":"Incorporation of PD-1 blockade into induction chemotherapy improved tumor response in patients with locoregionally advanced nasopharyngeal carcinoma in a retrospective patient cohort","volume":"154","author":"Yao","year":"2024","journal-title":"Oral Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189487_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41568-023-00578-2","article-title":"Defining and using immune archetypes to classify and treat cancer","volume":"23","author":"Combes","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2021.12.004","article-title":"Discovering dominant tumor immune archetypes in a pan-cancer census","volume":"185","author":"Combes","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2406052","article-title":"Clinical prognosticators and targets in the immune microenvironment of intrahepatic cholangiocarcinoma","volume":"13","author":"Lozzi","year":"2024","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189487_bb0050","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/2159-8290.CD-24-1012","article-title":"Ironing out the kinks: arming natural killer cells against ovarian cancer","volume":"14","author":"Bell","year":"2024","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189487_bb0055","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41590-024-01973-z","article-title":"GPR34 is a metabolic immune checkpoint for ILC1-mediated antitumor immunity","volume":"25","author":"Yan","year":"2024","journal-title":"Nat. Immunol."},{"issue":"7637","key":"10.1016\/j.bbcan.2025.189487_bb0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189487_bb0065","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189487_bb0070","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/ijc.31279","article-title":"Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: a large-scale cohort study","volume":"142","author":"Wang","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"23","key":"10.1016\/j.bbcan.2025.189487_bb0075","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1158\/1078-0432.CCR-21-0822","article-title":"Phase II, randomized study of spartalizumab (PDR001), an Anti-PD-1 antibody, versus chemotherapy in patients with recurrent\/metastatic nasopharyngeal cancer","volume":"27","author":"Even","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189487_bb0080","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41419-022-05171-3","article-title":"Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189487_bb0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12032-015-0501-6","article-title":"Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma","volume":"32","author":"Zhang","year":"2015","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41698-024-00601-1","article-title":"Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma","volume":"8","author":"Liu","year":"2024","journal-title":"NPJ Precis Oncol."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189487_bb0095","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1158\/1078-0432.CCR-21-3501","article-title":"The challenges of HLA class I loss in cancer immunotherapy: facts and hopes","volume":"28","author":"Aptsiauri","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"7528","key":"10.1016\/j.bbcan.2025.189487_bb0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0105","first-page":"12","article-title":"EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion","author":"Chen","year":"2024","journal-title":"J. Immunother. Cancer."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189487_bb0110","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.immuni.2022.07.021","article-title":"Successful anti-PD-1 Cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-gamma and IL-12","volume":"55","author":"Garris","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0115","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41467-024-48397-9","article-title":"FLI1 promotes IFN-gamma-induced kynurenine production to impair anti-tumor immunity","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189487_bb0125","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.7150\/thno.100171","article-title":"EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment","volume":"14","author":"Xiang","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0130","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1038\/s41467-018-07308-5","article-title":"Vasculogenic mimicry formation in EBV-associated epithelial malignancies","volume":"9","author":"Xiang","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189487_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O\u2019Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.84","article-title":"Epstein-Barr virus latent genes","volume":"47","author":"Kang","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2020.05.001","article-title":"Radiation-enhanced expression of CCL22 in nasopharyngeal carcinoma is associated with CCR4(+) CD8 T cell recruitment","volume":"108","author":"Li","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061887","article-title":"Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy","volume":"15","author":"Mahajan","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.bbcan.2025.189487_bb0155","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1097\/CM9.0000000000001745","article-title":"Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma","volume":"134","author":"Dong","year":"2021","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbcan.2025.189487_bb0160","doi-asserted-by":"crossref","first-page":"218038","DOI":"10.1016\/j.canlet.2025.218038","article-title":"Lactate metabolic checkpoint in Immuno-oncology: mechanisms and therapeutic implications","volume":"633","author":"Wang","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0165","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12951-024-02999-z","article-title":"Zinc-based radioenhancers to activate tumor radioimmunotherapy by PD-L1 and cGAS-STING pathway","volume":"22","author":"Xu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbcan.2025.189487_bb0170","doi-asserted-by":"crossref","first-page":"102300","DOI":"10.1016\/j.xcrm.2025.102300","article-title":"SOX4-ZIP14-zinc metabolism mediates oncogenesis and suppresses T cell immunity in nasopharyngeal carcinoma","volume":"6,9","author":"Yang","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cpan.2024.12.002","article-title":"Advances in drug discovery based on network pharmacology and omics technology","volume":"21","author":"Liu","year":"2024","journal-title":"Curr. Pharm. Anal."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0180","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1158\/2326-6066.CIR-22-0374","article-title":"EBV-upregulated B7-H3 inhibits NK cell\u2013mediated antitumor function and contributes to nasopharyngeal carcinoma progression","volume":"11","author":"Xiong","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189487_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011370","article-title":"Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer","volume":"13","author":"Khaw","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0190","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41591-025-03600-2","article-title":"A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1\/1b trial","volume":"31","author":"Ma","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12967-024-05104-y","article-title":"Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010200","article-title":"EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22","volume":"18","author":"Jorapur","year":"2022","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189487_bb0205","first-page":"1123","article-title":"Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Can."},{"issue":"10022","key":"10.1016\/j.bbcan.2025.189487_bb0210","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2025.189487_bb0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2020.02.010","article-title":"Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma","volume":"477","author":"Zhao","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cpan.2024.12.001","article-title":"Emerging trends and hot topics in the application of multi-omics in drug discovery: a bibliometric and visualized study","volume":"21","author":"Wang","year":"2024","journal-title":"Curr. Pharm. Anal."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189487_bb0225","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41422-020-00402-8","article-title":"Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma","volume":"30","author":"Jin","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0230","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41467-021-21795-z","article-title":"Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma","volume":"12","author":"Gong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189487_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101885","article-title":"The role of tertiary lymphoid structure and B cells in nasopharyngeal carcinoma: based on bioinformatics and experimental verification","volume":"41","author":"Chen","year":"2024","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0240","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/s41467-023-37614-6","article-title":"Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction","volume":"14","author":"Gong","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0245","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.immuni.2024.11.023","article-title":"Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis","volume":"58","author":"Diehl","year":"2025","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189487_bb0250","first-page":"1152","article-title":"Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells","volume":"147","author":"Agathanggelou","year":"1995","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-021-00702-4","article-title":"Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma","volume":"6","author":"Xie","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0260","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1111\/cts.13089","article-title":"An open-label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma","volume":"14","author":"De Meulenaere","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189487_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002101","article-title":"PD-1(+)CXCR5(\u2212)CD4(+) Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma","volume":"9","author":"Li","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2025.189487_bb0270","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jare.2023.04.001","article-title":"ENOX2 inhibition enhances infiltration of effector memory T-cell and mediates response to chemotherapy in immune-quiescent nasopharyngeal carcinoma","volume":"56","author":"Kam","year":"2024","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1158\/2159-8290.CD-15-0510","article-title":"Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells","volume":"6","author":"Sanchez-Paulete","year":"2016","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189487_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114868","article-title":"PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy","volume":"43","author":"Xiao","year":"2024","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0285","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12964-024-01799-0","article-title":"Tumor-associated macrophage-derived itaconic acid contributes to nasopharyngeal carcinoma progression by promoting immune escape via TET2","volume":"22","author":"Zhang","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189487_bb0290","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1158\/0008-5472.CAN-16-2706","article-title":"Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages","volume":"77","author":"Huang","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008146","article-title":"HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype","volume":"12","author":"Luo","year":"2024","journal-title":"J. Immunother. Cancer."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0300","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1186\/s12967-024-05935-9","article-title":"Lactate-related gene signatures as prognostic predictors and comprehensive analysis of immune profiles in nasopharyngeal carcinoma","volume":"22","author":"Liu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0305","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41423-023-01112-y","article-title":"The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation","volume":"21","author":"Luo","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"26","key":"10.1016\/j.bbcan.2025.189487_bb0310","article-title":"C1q(+) macrophage-tumor cell interaction promoted tumorigenesis via GPR17\/PI3K\/AKT pathway induced DNA Hypermethylation in nasopharyngeal carcinoma","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci. (Weinh)."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189487_bb0315","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41568-023-00549-7","article-title":"The advent of immune stimulating CAFs in cancer","volume":"23","author":"Tsoumakidou","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189487_bb0320","first-page":"793","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat. Can."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189487_bb0325","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189487_bb0330","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","article-title":"CellPhoneDB: inferring cell\u2013cell communication from combined expression of multi-subunit ligand\u2013receptor complexes","volume":"15","author":"Mirjana Efremova","year":"2020","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189487_bb0335","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189487_bb0340","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccell.2023.03.008","article-title":"Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-beta activation","volume":"41","author":"Mousset","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189487_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104357","article-title":"Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma","volume":"86","author":"Ka-Yue Chow","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0350","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1038\/s41467-021-24348-6","article-title":"Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-kappaB activation and immune escape","volume":"12","author":"Bruce","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189487_bb0355","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002014","article-title":"Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma","volume":"9","author":"Ma","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0360","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02168-16","article-title":"Epstein-barr virus-encoded latent membrane protein 1 upregulates glucose transporter 1 transcription via the mTORC1\/NF-kappaB signaling pathways","volume":"91","author":"Zhang","year":"2017","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189487_bb0365","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1361","article-title":"METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma","volume":"13","author":"Hu","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189487_bb0370","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2025.02.002","article-title":"Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma","volume":"43","author":"Lam","year":"2025","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189487_bb0375","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cncr.34005","article-title":"Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma","volume":"128","author":"Leupin","year":"2022","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189487_bb0380","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/cas.16079","article-title":"Soluble CD27 as a predictive biomarker for intra-tumoral CD70\/CD27 interaction in nasopharyngeal carcinoma","volume":"115","author":"Nagato","year":"2024","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0385","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41698-024-00558-1","article-title":"Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma","volume":"8","author":"Ma","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189487_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70061","article-title":"Single-cell transcriptome analysis reveals evolving tumour microenvironment induced by immunochemotherapy in nasopharyngeal carcinoma","volume":"14","author":"Jiang","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0395","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12951-025-03315-z","article-title":"PTEN as a prognostic factor for radiotherapy plus immunotherapy response in nasopharyngeal carcinoma","volume":"23","author":"Guo","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189487_bb0400","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00262-024-03928-7","article-title":"KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapy","volume":"74","author":"Chen","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2025.189487_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1492648","article-title":"m6A methylation profiling as a prognostic marker in nasopharyngeal carcinoma: insights from MeRIP-Seq and RNA-Seq","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189487_bb0410","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2174\/1874467215666220705142954","article-title":"Carvacrol as a prospective regulator of cancer targets\/signalling pathways","volume":"16","author":"Singh","year":"2023","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189487_bb0415","article-title":"At the crossroads of TNF alpha signaling and cancer","volume":"17","author":"Manohar","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0420","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","article-title":"The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment","volume":"29","author":"Lv","year":"2023","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0425","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-021-01317-7","article-title":"Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cancer"},{"issue":"35","key":"10.1016\/j.bbcan.2025.189487_bb0430","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1200\/JCO.2005.02.6195","article-title":"Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes","volume":"23","author":"Comoli","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.bbcan.2025.189487_bb0435","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2025.1132","article-title":"Adjuvant PD-1 blockade with camrelizumab for nasopharyngeal carcinoma: the DIPPER randomized clinical trial","volume":"333","author":"Liang","year":"2025","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189487_bb0440","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S1470-2045(24)00504-7","article-title":"Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-Centre, double-blind, placebo-controlled, phase 2 trial","volume":"25","author":"Liu","year":"2024","journal-title":"Lancet Oncol."},{"issue":"10445","key":"10.1016\/j.bbcan.2025.189487_bb0445","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/S0140-6736(24)00594-4","article-title":"Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial","volume":"403","author":"Liu","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189487_bb0450","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189487_bb0455","doi-asserted-by":"crossref","first-page":"14121","DOI":"10.1038\/ncomms14121","article-title":"Exome and genome sequencing of nasopharynx cancer identifies NF-kappaB pathway activating mutations","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189487_bb0460","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.gendis.2021.07.002","article-title":"The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: predictive value and immunotherapy implications","volume":"9","author":"Yang","year":"2022","journal-title":"Genes Dis."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189487_bb0465","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/cac2.12619","article-title":"Targeting the LMP1-ALIX axis in EBV(+) nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity","volume":"44","author":"He","year":"2024","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.bbcan.2025.189487_bb0470","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41586-024-08562-y","article-title":"An early precursor CD8 T cell that adapts to acute or chronic viral infection","volume":"640","author":"McManus","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0475","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-021-21043-4","article-title":"Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189487_bb0480","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJMra1911109","article-title":"Tolerance in the age of immunotherapy","volume":"383","author":"Bluestone","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0485","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13059-025-03657-9","article-title":"A genome-wide association study integrated with single-cell and bulk profiles uncovers susceptibility genes for nasopharyngeal carcinoma involved in tumorigenesis via regulation of T cells","volume":"26","author":"Wang","year":"2025","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbcan.2025.189487_bb0490","article-title":"PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinoma","volume":"14","author":"Li","year":"2024","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189487_bb0495","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1073\/pnas.1621280114","article-title":"CCR8(+)FOXp3(+) T(reg) cells as master drivers of immune regulation","volume":"114","author":"Barsheshet","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2025","key":"10.1016\/j.bbcan.2025.189487_bb0500","first-page":"93","article-title":"Harnessing the biology of regulatory T cells to treat disease","author":"Wardell","year":"2024","journal-title":"Nat. Rev. Drug Discov24."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189487_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315142","article-title":"Excess BAFF alters NR4As expression levels and Breg function of human precursor-like marginal zone B-cells in the context of HIV-1 infection","volume":"23","author":"Doyon-Laliberte","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189487_bb0510","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41590-020-0765-7","article-title":"NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting","volume":"21","author":"Tan","year":"2020","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189487_bb0515","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.immuni.2012.08.001","article-title":"The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells","volume":"37","author":"Li","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189487_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2024.106999","article-title":"Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1(hi) and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment","volume":"158","author":"Ge","year":"2024","journal-title":"Oral Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189487_bb0525","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","article-title":"Differential macrophage programming in the tumor microenvironment","volume":"33","author":"Ruffell","year":"2012","journal-title":"Trends Immunol."},{"issue":"16","key":"10.1016\/j.bbcan.2025.189487_bb0530","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/onc.2013.161","article-title":"LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation","volume":"33","author":"Liao","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0535","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13046-018-0814-3","article-title":"Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK\/AKT pathway in nasopharyngeal carcinoma","volume":"37","author":"Lu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0540","doi-asserted-by":"crossref","first-page":"652","DOI":"10.21147\/j.issn.1000-9604.2024.06.05","article-title":"Fatty acid metabolism: a new target for nasopharyngeal carcinoma therapy","volume":"36","author":"Li","year":"2024","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189487_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113944","article-title":"SPP1-mediated M2 macrophage polarization shapes the tumor microenvironment and enhances prognosis and immunotherapy guidance in nasopharyngeal carcinoma","volume":"147","author":"Huang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2025.189487_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594775","article-title":"Tumor cell-secreted ISG15 promotes tumor cell migration and immune suppression by inducing the macrophage M2-like phenotype","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0555","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13046-025-03290-1","article-title":"Myeloid cell-derived apCAFs promote HNSCC progression by regulating proportion of CD4(+) and CD8(+) T cells","volume":"44","author":"Ren","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0560","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-021-01878-x","article-title":"Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-kappaB pathway","volume":"40","author":"Huang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0565","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1038\/s41467-024-52153-4","article-title":"Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010052","article-title":"Specific immune responses and oncolytic effects induced by EBV LMP2A-armed modified Ankara-vaccinia virus vectored vaccines in nasopharyngeal cancer","volume":"17","author":"Sun","year":"2025","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189487_bb0575","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001588","article-title":"EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells","volume":"8","author":"Huo","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0580","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-023-01928-2","article-title":"Nasopharyngeal carcinoma: current views on the tumor microenvironment\u2019s impact on drug resistance and clinical outcomes","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0585","doi-asserted-by":"crossref","first-page":"31943","DOI":"10.1038\/s41598-024-83423-2","article-title":"The IL-10\/STAT3 Axis nasopharyngeal carcinoma cancer stem cell and radio resistance","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.bbcan.2025.189487_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413452","article-title":"Epstein-Barr virus BRRF1 induces Butyrophilin 2A1 in nasopharyngeal carcinoma NPC43 cells via the IL-22\/JAK3-STAT3 pathway","volume":"25","author":"Liu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189487_bb0595","first-page":"0475","article-title":"Blind brush biopsy: quantification of Epstein-Barr virus and its host DNA methylation in the detection of nasopharyngeal carcinoma","volume":"7","author":"Tang","year":"2024","journal-title":"Research (Wash D.C.)"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189487_bb0600","first-page":"219","article-title":"miR-34c-3p inhibits nasopharyngeal carcinoma development via inhibiting M2 polarization of macrophages","volume":"38","author":"Ji","year":"2025","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.bbcan.2025.189487_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115404","article-title":"Deciphering the metabolic-epigenetic-immune crosstalk in Epstein-Barr virus-positive nasopharyngeal carcinoma: mechanisms and novel therapeutic frontiers","volume":"164","author":"Lin","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0610","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41419-025-07444-z","article-title":"Tumor vascular endothelial cells promote immune escape by upregulating PD-L1 expression via crosstalk between NF-kappaB and STAT3 signaling pathways in nasopharyngeal carcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0615","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.84","article-title":"Human leukocyte antigen (HLA) class I expression on Hodgkin-reed-Sternberg cells is an EBV-independent major determinant of microenvironment composition in classic Hodgkin lymphoma","volume":"8","author":"Muller-Meinhard","year":"2024","journal-title":"Hemasphere"},{"key":"10.1016\/j.bbcan.2025.189487_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1633243","article-title":"Short-course PD-1 blockade in locally advanced nasopharyngeal carcinoma: a phase II randomized trial protocol (Tori-013)","volume":"16","author":"Jia","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0625","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12916-025-03964-9","article-title":"Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China","volume":"23","author":"Wang","year":"2025","journal-title":"BMC Med."},{"issue":"28","key":"10.1016\/j.bbcan.2025.189487_bb0630","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41388-024-03061-w","article-title":"Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1alpha-VEGF pathway","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0635","first-page":"10","article-title":"Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes","volume":"1","author":"Zhang","year":"2025","journal-title":"Med. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0640","first-page":"62","article-title":"Breaking boundaries: chronic diseases and the frontiers of immune microenvironments","volume":"1","author":"Li","year":"2025","journal-title":"Med. Res."},{"key":"10.1016\/j.bbcan.2025.189487_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106231","article-title":"The efficacy and safety of VEGF\/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis","volume":"135","author":"Xue","year":"2022","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0650","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7150\/ijbs.66506","article-title":"Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling","volume":"18","author":"Wu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0655","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13046-018-0769-4","article-title":"Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt\/beta-catenin-Lin28\/let7-PDK1 cascade","volume":"37","author":"Cai","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189487_bb0660","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.4575","article-title":"Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells","volume":"237","author":"Lo","year":"2015","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0665","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.yexcr.2017.08.005","article-title":"Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by Epstein-Barr virus latent membrane protein 1","volume":"359","author":"Sung","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"37","key":"10.1016\/j.bbcan.2025.189487_bb0670","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1038\/onc.2014.32","article-title":"Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy","volume":"33","author":"Xiao","year":"2014","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189487_bb0675","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/cas.12818","article-title":"Matrix metalloproteinase 13-containing exosomes promote nasopharyngeal carcinoma metastasis","volume":"106","author":"You","year":"2015","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0680","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12935-022-02787-5","article-title":"Extracellular matrix stiffness mediates radiosensitivity in a 3D nasopharyngeal carcinoma model","volume":"22","author":"Fang","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189487_bb0685","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12390","article-title":"Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin-9 dependent mechanism","volume":"12","author":"Lefebvre","year":"2023","journal-title":"J. Extracell. Vesicles."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0690","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41420-023-01621-9","article-title":"SCARB1 in extracellular vesicles promotes NPC metastasis by co-regulating M1 and M2 macrophage function","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"issue":"20","key":"10.1016\/j.bbcan.2025.189487_bb0695","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1001\/jama.2023.20181","article-title":"Toripalimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: the JUPITER-02 randomized clinical trial","volume":"330","author":"Mai","year":"2023","journal-title":"JAMA"},{"issue":"33","key":"10.1016\/j.bbcan.2025.189487_bb0700","article-title":"TMEM52B isoforms P18 and P20 differentially promote the oncogenesis and metastasis of nasopharyngeal carcinoma","volume":"11","author":"Zhu","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189487_bb0705","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1080\/15384101.2023.2216508","article-title":"Exosomal miR-18a-5p promotes EMT and metastasis of NPC cells via targeting BTG3 and activating the Wnt\/beta-catenin signaling pathway","volume":"22","author":"Zhong","year":"2023","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189487_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020818","article-title":"The miRNA-185-5p\/STIM1 Axis regulates the invasiveness of nasopharyngeal carcinoma cell lines by modulating EGFR activation-stimulated switch from E- to N-cadherin","volume":"28","author":"Luo","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbcan.2025.189487_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2024.106798","article-title":"The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-beta1\/Smads\/Snail1 axis","volume":"152","author":"Li","year":"2024","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0720","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1038\/s41598-023-40041-8","article-title":"HOXA13 promotes the proliferation, migration, and invasion of nasopharyngeal carcinoma HNE1 cells by upregulating the expression of Snail and MMP-2","volume":"13","author":"Liu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189487_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120558","article-title":"PGC1alpha-mediated fatty acid oxidation promotes TGFbeta1-induced epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma","volume":"300","author":"Quan","year":"2022","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189487_bb0730","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.immuni.2025.08.009","article-title":"Multi-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation","volume":"58","author":"Liao","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189487_bb0735","article-title":"Analysis of head and neck cancer scRNA-seq data identified PRDM6 promotes tumor progression by modulating immune gene expression","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189487_bb0740","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.7150\/thno.82690","article-title":"Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal \"unity of ecology and evolution\" pathological ecosystem","volume":"13","author":"Luo","year":"2023","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0745","article-title":"Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes","volume":"6","author":"Yeo","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2025.189487_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2025.08.004","article-title":"The coming era of nudge drugs for cancer","author":"Courau","year":"2025","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189487_bb0755","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011636","article-title":"Single-cell RNA sequencing of baseline PBMCs predicts ICI efficacy and irAE severity in patients with NSCLC","volume":"13","author":"Kim","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0760","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","article-title":"Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4(+) T cells in head and neck cancer","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189487_bb0765","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.7150\/thno.108925","article-title":"Single-nucleus RNA sequencing and spatial transcriptomics reveal an immunosuppressive tumor microenvironment related to metastatic dissemination during pancreatic cancer liver metastasis","volume":"15","author":"Liu","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0770","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12967-023-03912-2","article-title":"High proportion of circulating CD8 + CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal canrcinoma after radiotherapy","volume":"21","author":"Xu","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"100","key":"10.1016\/j.bbcan.2025.189487_bb0780","article-title":"Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4 T cell response +","volume":"9","author":"Aleksey Chudnovskiy","year":"2024","journal-title":"Sci. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189487_bb0785","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","article-title":"Successful anti-PD-1 Cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-gamma and IL-12","volume":"49","author":"Garris","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189487_bb0790","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41423-024-01253-8","article-title":"Cell-associated galectin 9 interacts with cytotoxic T cells confers resistance to tumor killing in nasopharyngeal carcinoma through autophagy activation","volume":"22","author":"Kam","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0795","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13045-025-01666-6","article-title":"Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib\/II trial","volume":"18","author":"Chen","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189487_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111047","article-title":"Harnessing deep learning to optimize induction chemotherapy choices in nasopharyngeal carcinoma","volume":"211","author":"Chen","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2025.189487_bb0805","first-page":"0749","article-title":"Radiomic model associated with tumor microenvironment predicts immunotherapy response and prognosis in patients with Locoregionally advanced nasopharyngeal carcinoma","volume":"8","author":"Sun","year":"2025","journal-title":"Research (Wash D.C.)"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189487_bb0810","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.230544","article-title":"A serial MRI-based deep learning model to predict survival in patients with Locoregionally advanced nasopharyngeal carcinoma","volume":"7","author":"Kou","year":"2025","journal-title":"Radiol. Artif. Intell."},{"key":"10.1016\/j.bbcan.2025.189487_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112407","article-title":"Efficient T staging in nasopharyngeal carcinoma via deep learning-based multi-modal classification","volume":"192","author":"Song","year":"2025","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189487_bb0820","doi-asserted-by":"crossref","DOI":"10.1172\/JCI182768","article-title":"Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma","volume":"135","author":"Zeng","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189487_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115749","article-title":"A multicenter retrospective analysis of recurrent\/metastatic nasopharyngeal cancer from non-endemic areas: results in the pre-immunotherapy era","volume":"229","author":"Alberti","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189487_bb0830","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.7150\/thno.53229","article-title":"Neoantigen landscape in metastatic nasopharyngeal carcinoma","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2500229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2500229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:42:22Z","timestamp":1781066542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X2500229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":166,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0304419X2500229X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189487","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune archetypes TIME classification system for nasopharyngeal carcinoma: A new direction for precision immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189487"}}